JP2019508403A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019508403A5 JP2019508403A5 JP2018540794A JP2018540794A JP2019508403A5 JP 2019508403 A5 JP2019508403 A5 JP 2019508403A5 JP 2018540794 A JP2018540794 A JP 2018540794A JP 2018540794 A JP2018540794 A JP 2018540794A JP 2019508403 A5 JP2019508403 A5 JP 2019508403A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleic acid
- polynucleotide sequence
- vaccine
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662291601P | 2016-02-05 | 2016-02-05 | |
| US62/291,601 | 2016-02-05 | ||
| PCT/US2017/016557 WO2017136758A1 (en) | 2016-02-05 | 2017-02-03 | Cancer vaccines and methods of treatment using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019508403A JP2019508403A (ja) | 2019-03-28 |
| JP2019508403A5 true JP2019508403A5 (enExample) | 2020-03-19 |
| JP7123800B2 JP7123800B2 (ja) | 2022-08-23 |
Family
ID=59500919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018540794A Active JP7123800B2 (ja) | 2016-02-05 | 2017-02-03 | がんのワクチン及びそれを用いた処置の方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US11007255B2 (enExample) |
| EP (1) | EP3411122A4 (enExample) |
| JP (1) | JP7123800B2 (enExample) |
| KR (2) | KR102742526B1 (enExample) |
| CN (2) | CN118184761A (enExample) |
| AU (2) | AU2017214656B2 (enExample) |
| BR (1) | BR112018015893A2 (enExample) |
| CA (1) | CA3013718C (enExample) |
| MX (2) | MX2018009506A (enExample) |
| WO (1) | WO2017136758A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017214656B2 (en) * | 2016-02-05 | 2022-08-25 | Inovio Pharmaceuticals, Inc. | Cancer vaccines and methods of treatment using the same |
| WO2018217982A1 (en) * | 2017-05-26 | 2018-11-29 | The Wistar Institute Of Anatomy And Biology | Dtert vaccines and methods of treatment using the same |
| CA3080835A1 (en) | 2017-10-31 | 2019-05-09 | Pantarhei Bioscience B.V. | Immunotherapeutic methods for treating and/or preventing lung cancer |
| RU2759681C1 (ru) | 2017-12-13 | 2021-11-16 | Иновио Фармасьютикалз, Инк. | Противораковые вакцины, нацеленные на boris, и способы их применения |
| SG11202106378VA (en) | 2018-12-21 | 2021-07-29 | Ionis Pharmaceuticals Inc | Modulators of hsd17b13 expression |
| WO2021259963A1 (en) | 2020-06-23 | 2021-12-30 | Pandora Endocrine Innovation B.V. | Immunization against wnt4 for treatment and prophylaxis of breast cancer |
| US20250026818A1 (en) | 2021-10-19 | 2025-01-23 | Sciencemed Spóka z ograniczon odpowiedzialnoci | Male contraception |
| WO2023237726A1 (en) | 2022-06-10 | 2023-12-14 | Pantarhei Oncology B.V. | An intracellular tumor-specific variant of human zona pellucida glycoprotein 3 and nucleic acids coding therefor for use in the treatment of cancer |
| WO2025146078A1 (en) * | 2024-01-04 | 2025-07-10 | Everest Medicines (China) Co., Ltd. | Cancer vaccines and uses thereof |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US5036006A (en) | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| EP0646178A1 (en) | 1992-06-04 | 1995-04-05 | The Regents Of The University Of California | expression cassette with regularoty regions functional in the mammmlian host |
| US5273525A (en) | 1992-08-13 | 1993-12-28 | Btx Inc. | Injection and electroporation apparatus for drug and gene delivery |
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| US5981505A (en) | 1993-01-26 | 1999-11-09 | The Trustees Of The University Of Pennsylvania | Compositions and methods for delivery of genetic material |
| ES2249760T3 (es) | 1993-01-26 | 2006-04-01 | The Trustees Of The University Of Pennsylvania (A Corporation Of Pennsylvania) | Composiciones y procedimientos de administracion de materias geneticas. |
| US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| NL9401820A (nl) | 1994-11-02 | 1996-06-03 | Meyn Maschf | Inrichting voor het bewerken van aan zijn poten opgehangen gevogelte. |
| US5962428A (en) | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| WO1998043702A2 (en) | 1997-04-03 | 1998-10-08 | Iacob Mathiesen | Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle |
| US6261281B1 (en) | 1997-04-03 | 2001-07-17 | Electrofect As | Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
| CA2294793A1 (fr) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede |
| EP2428250A1 (en) | 1998-07-13 | 2012-03-14 | Genetronics, Inc. | Skin and muscle-targeted gene therapy by pulsed electrical field |
| US7245963B2 (en) | 2002-03-07 | 2007-07-17 | Advisys, Inc. | Electrode assembly for constant-current electroporation and use |
| US8209006B2 (en) | 2002-03-07 | 2012-06-26 | Vgx Pharmaceuticals, Inc. | Constant current electroporation device and methods of use |
| US7328064B2 (en) | 2002-07-04 | 2008-02-05 | Inovio As | Electroporation device and injection apparatus |
| EP1573004A4 (en) | 2002-11-04 | 2006-08-09 | Advisys Inc | SYNTHETIC MUSCLE PROMOTERS WITH INHERENT CELLS NATURALLY OBTAINING REGULATORY SEQUENCES EXCELLENT ACTIVITIES |
| US7238522B2 (en) | 2003-05-30 | 2007-07-03 | Advisys, Inc. | Devices and methods for biomaterial production |
| KR102511874B1 (ko) * | 2006-07-28 | 2023-03-20 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 개선된 백신 및 이의 사용 방법 |
| CN101522706B (zh) * | 2006-10-12 | 2013-09-04 | P.安杰莱蒂分子生物学研究所 | 端粒酶逆转录酶融合蛋白、编码它的核苷酸以及其用途 |
| AU2007313203B2 (en) | 2006-10-17 | 2012-08-16 | Vgx Pharmaceuticals, Llc | Electroporation devices and methods of using same for electroporation of cells in mammals |
| ES2622418T3 (es) | 2007-05-23 | 2017-07-06 | Vgxi, Inc. | Composición que comprende alta concentración de moléculas biológicamente activas y procesos para preparar la misma |
| WO2013019603A2 (en) * | 2011-07-29 | 2013-02-07 | Inovio Pharmaceuticals, Inc. | Linear expression cassettes and uses thereof |
| MX428954B (es) | 2013-03-15 | 2025-11-13 | Univ Pennsylvania | Vacunación mejorada contra la hormona liberadora de la hormona de crecimiento (ghrh) humana. |
| AU2014242916B2 (en) * | 2013-03-28 | 2018-08-02 | Invectys | A cancer vaccine for dogs |
| US10398769B2 (en) * | 2013-08-06 | 2019-09-03 | The Trustees Of The University Of Pennsylvania | Influenza nucleic acid molecules and vaccines made therefrom |
| AU2017214656B2 (en) * | 2016-02-05 | 2022-08-25 | Inovio Pharmaceuticals, Inc. | Cancer vaccines and methods of treatment using the same |
| WO2018217982A1 (en) * | 2017-05-26 | 2018-11-29 | The Wistar Institute Of Anatomy And Biology | Dtert vaccines and methods of treatment using the same |
-
2017
- 2017-02-03 AU AU2017214656A patent/AU2017214656B2/en not_active Ceased
- 2017-02-03 CN CN202410352664.8A patent/CN118184761A/zh active Pending
- 2017-02-03 CA CA3013718A patent/CA3013718C/en active Active
- 2017-02-03 CN CN201780020641.5A patent/CN108883312B/zh active Active
- 2017-02-03 BR BR112018015893A patent/BR112018015893A2/pt active Search and Examination
- 2017-02-03 MX MX2018009506A patent/MX2018009506A/es unknown
- 2017-02-03 KR KR1020187025572A patent/KR102742526B1/ko active Active
- 2017-02-03 WO PCT/US2017/016557 patent/WO2017136758A1/en not_active Ceased
- 2017-02-03 KR KR1020247040786A patent/KR20250002803A/ko active Pending
- 2017-02-03 JP JP2018540794A patent/JP7123800B2/ja active Active
- 2017-02-03 US US16/075,527 patent/US11007255B2/en active Active
- 2017-02-03 EP EP17748295.7A patent/EP3411122A4/en active Pending
-
2018
- 2018-08-03 MX MX2023001540A patent/MX2023001540A/es unknown
-
2021
- 2021-04-09 US US17/226,633 patent/US11801288B2/en active Active
-
2022
- 2022-11-17 AU AU2022271441A patent/AU2022271441B2/en not_active Expired - Fee Related
-
2023
- 2023-09-22 US US18/472,640 patent/US20240082374A1/en not_active Abandoned
-
2025
- 2025-06-25 US US19/248,819 patent/US20250319178A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230293608A1 (en) | Oncolytic Vaccinia Virus | |
| JP2019193662A5 (enExample) | ||
| Cerullo et al. | Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans | |
| JP2015533841A5 (enExample) | ||
| RU2016145464A (ru) | Рекомбинантные вакцинные штаммы listeria и способы их получения | |
| PH12020500670A1 (en) | Molecular adjuvant | |
| WO2017205810A8 (en) | Neoepitope vaccine compositions and methods of use thereof | |
| JP2016516723A5 (enExample) | ||
| JP2016539946A5 (enExample) | ||
| WO2017209053A1 (ja) | 新規な遺伝子組換えワクシニアウイルス | |
| JP2016533749A5 (enExample) | ||
| RU2019107976A (ru) | Композиция вакцины | |
| JP2020528911A5 (enExample) | ||
| MX2017000838A (es) | Cepa de listeria recombinante que expresa proteinas de fusion con antigenos heterologos y metodos para el uso de estas. | |
| JP2015506179A5 (enExample) | ||
| RU2015103758A (ru) | Днк-вакцина для применения у пациентов с раком поджелудочной железы | |
| JP2014207903A5 (enExample) | ||
| WO2011119925A3 (en) | Synthetic herpes simplex viruses for treatment of cancers | |
| JP2020511139A5 (enExample) | ||
| RU2018123307A (ru) | Вакцинация с использованием альфа3 домена mica/b для лечения рака | |
| RU2019132253A (ru) | Новая днк-вакцина, нацеленная на pd-l1, для иммунотерапии рака | |
| RU2016108808A (ru) | Терапевтическое применение vegf-c и ccbe1 | |
| JP2018522041A5 (enExample) | ||
| FI3737397T3 (fi) | Prameen kohdistetut syöpärokotteet ja niiden käytöt | |
| JP2014139185A5 (enExample) |